Advertisement
Document › Details
EuropaBio. (9/3/20). "Press Release: Novartis’s Andrew Topen Appointed as New Chairman of EuropaBio".
Region | Europe | |
Organisation | EuropaBio aisbl – the European Association of Bioindustries | |
Organisation 2 | Novartis AG (NYSE: NVS) | |
Group | Novartis (Group) | |
Product | BIOTECH | |
Product 2 | public relations / investor relations / marcom (services) | |
Person | Topen, Andrew (EuropaBio 202009– Chairman main org Novartis before Pfizer + GSK) | |
Person 2 | de Ruiter, Tjerk (EuropaBio 201809 Chair) | |
Today, EuropaBio’s General Assembly confirmed the appointment of Andrew Topen as the new Chairman of the association. Andrew Topen joined Novartis in September 2019 and has since then lead the overall public affairs strategy and strategic relationships within Region Europe.
Commenting on his appointment, Andrew Topen highlighted: ‘I am proud to take over the chairmanship of EuropaBio at a time when biotechnology is so critical to tackle society’s greatest challenges. EuropaBio holds a unique position to promote biotechnology innovations to the benefit of people and the planet. EuropaBio has an important role to play in shaping the European Green Deal and the Farm to Fork, the Industrial, Pharmaceutical and Digital strategies to set the course towards Europe’s economic recovery and the fight against climate change. Life sciences and biotechnology are making a healthier, more resilient, and sustainable Europe possible, one that is able to swiftly recover from the current crisis and delivers for its citizens, its regions, and its economy. I would like to thank Tjerk de Ruiter for his leadership of EuropaBio over the last two years and the EuropaBio team for their ongoing efforts to advance biotechnology in Europe.’
ENDS
Media contact
Kai Künnecke, EuropaBio Communications Officer
Email: k.kuennecke@europabio.org/ Telephone: +32 2 739 11 81
About EuropaBio
EuropaBio, the European Association for Bioindustries, promotes an innovative and dynamic European biotechnology industry. EuropaBio and its members are committed to the socially responsible use of biotechnology to improve quality of life, to prevent, diagnose, treat and cure diseases, to improve the quality and quantity of food and feedstuffs and to move towards a biobased and zero-waste economy. EuropaBio represents 75 corporate members and 17 national biotechnology associations and bioregions.
Read more about our work at www.europabio.org.
Record changed: 2023-06-05 |
Advertisement
More documents for EuropaBio aisbl – the European Association of Bioindustries
- [1] EuropaBio. (11/2/20). "Press Release: EuropaBio Announces Dr Claire Skentelbery as New Director General of the Association". Brussels....
- [2] EuropaBio. (9/3/18). "Press Release: EuropaBio Appoints New Secretary General, Healthcare Director and Industrial Biotech Director". Brussels....
- [3] EFPIA. (2/22/17). "Press Release: Nathalie Moll Announced as New EFPIA Director General, Starting in April 2017"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top